1. Introduction {#s0005}
===============

Stressful situations require a prompt response of the organism to promote adaptation and survival ([@bb0160]). Hypothalamus-pituitary-adrenal (HPA) axis functionality is essential for such a response, and depends on many mediators, such as steroid hormones (*e.g.* cortisol), neurotransmitters (including glutamate and GABA), cytokines, and neuropeptides, which all function in time- and brain area-dependent manners ([@bb0115]). The hippocampus, amygdala and prefrontal cortex (PFC) are particularly interesting regions, as they project onto the HPA axis *via* the inhibitory GABA and excitatory glutamate system ([@bb0240]), but the stress-related dynamics of these systems largely remain unclear. Of note, stress exposure generally increases prefrontal cortex glutamate levels in the rodent brain (for review see ([@bb0190])) and mostly decreases brain GABA levels, depending on the type and duration of stress, and the brain region examined ([@bb0005], [@bb0030], [@bb0050], [@bb0070], [@bb0100], [@bb0175], [@bb0180]). In addition, rapid changes in GABA(A) receptors occur after acute stress in animals ([@bb0230]).

In contrast to the abundance of animal studies examining the relation between stress and GABA/glutamate levels, human studies are scarce. Currently, the only method to directly measure GABA and glutamate levels in the living human brain is proton magnetic resonance spectroscopy (^1^H-MRS). Using ^1^H-MRS to detect stress-related differences in metabolite levels in the PFC, one study reported increased glutamate + glutamine levels after chemically induced panic ([@bb0275]) and another study showed decreasing GABA levels under threat of shock ([@bb0105]). However, to the best of our knowledge, the influence of acute psychosocial stress on GABA and glutamate levels in the human brain is unknown. Investigating the mechanisms underlying psychosocial stress is relevant in light of the impact of repeated psychosocial stress exposure on the risk for and course of psychiatric disorders ([@bb0055], [@bb0135]).

Recent technical developments at a field strength of 7 Tesla (T) enable improved measurement of *in vivo* glutamate and GABA levels in the human brain ([@bb0045], [@bb0170]). Scanning at higher field strength yields greater spectral dispersion and thereby more reliable signal quantification ([@bb0095]), which is of particular interest since glutamate and especially GABA are present at low concentrations in the brain (5--15 mmol/kg ([@bb0095]) and ± 1 mmol/kg ([@bb0265]), respectively).

Therefore, we aimed to investigate acute psychosocial stress-induced changes in glutamate and GABA levels in the human medial PFC (mPFC) as measured with ^1^H-MRS in a 7T MRI scanner. Based on the available studies in rodents ([@bb0075], [@bb0175], [@bb0190], [@bb0230]), we hypothesized that, compared to the control condition, stress would increase glutamate levels and decrease GABA levels in the human mPFC.

2. Material and methods {#s0010}
=======================

2.1. Participants {#s0015}
-----------------

Healthy non-smoking male individuals (age 18--40, *N* = 30) were recruited from the general population in The Netherlands (see [Table 1](#t0005){ref-type="table"}). Participants did not take any medication and had not previously been enrolled in any stress-related research. The absence of mental disorders according to DSM-IV criteria was confirmed using the Mini International Neuropsychiatric Interview (MINI)-plus ([@bb0225]) conducted by a trained rater. On the day of the test, participants did not take heavy meals or drinks other than water and they abstained from heavy exercise for at least 2 h prior to arrival. Absence of psychoactive substance use (amphetamines, MDMA, barbiturates, cannabinoids, benzodiazepines, cocaine, and opiates) was determined by self-report and verified with a urine multi-drug screening device (InstantView) ([@bb0255]).Table 1Baseline sample characteristics in the total sample and per condition.Table 1VariableTotal (n = 29)Control (n = 14)Stress (n = 15)Mean age in years (SD)24 (5)23 (5)25 (5)Childhood maltreatment (mean, range)31 (25--44)31 (27--39)32 (25--44)Major life events (mean, range)2.5 (0--6)2.6 (0--5)2.5 (0--6)Daily hassles (mean, range)17.6 (5--44)16.9 (5--44)18.5 (6--44)

2.2. General {#s0020}
------------

All experimental procedures were approved by the ethical review board of the University Medical Center Utrecht and performed according to the ICH guidelines for Good Clinical Practice and the Declaration of Helsinki. We measured GABA and glutamate levels in the mPFC of participants who were randomized to either the validated stress (*N* = 15) or control (*N* = 15) condition of the Trier Social Stress Test (TSST) ([@bb0130]). During a first visit, participants were familiarized with the 7T MRI scanner environment and scanning procedure with a 15-minute scan session to reduce any potential stressful associations with the scanning environment. Throughout the second visit, participants completed a 120-minute protocol during which GABA and glutamate levels were quantified in the mPFC before (time point 1) and 30 min after (time point 2) exposure to either the stress or the control condition ([Fig. 1](#f0005){ref-type="fig"}). Scanning around 30 min after stress exposure (time point 2) was selected to coincide with the cortisol peak of the stress response ([@bb0255]).Fig. 1Cortisol levels over time before and after exposure to the control condition (*N* = 15) or the stress condition (*N* = 14). The dotted lines represent the standard error. \* = *p*-value \< 0.01 (comparing the stress to the control condition in the posthoc test per time point).Fig. 1

2.3. Stress and control conditions {#s0025}
----------------------------------

All experimental conditions were carried out between 2 PM--9 PM to minimize diurnal variations of cortisol secretion. The stress condition was carried out in accordance with previously published methods ([@bb0130]). Five minutes before the stress or control intervention, all participants received written instructions. In the stress condition, participants delivered a public speech and performed a challenging mental arithmetic while being seemingly videotaped and recorded in front of an evaluative panel that did not show any signs of social support. The combination of an evaluated public speech and cognitive task reliably stimulates the HPA axis by integrating uncontrollability with threat to the social self and self-esteem. The control condition consisted of a speech and simple arithmetic without the presence of a video camera or evaluative panel. Thus the control task has a comparable cognitive load without the social evaluative aspects that stimulate the HPA axis ([@bb0110]). Salivary cortisol levels were measured using six saliva samples (Salivettes) collected over a 120-minute time period (from 60 min prior to the experimental condition up to 60 min afterwards, [Fig. 1](#f0005){ref-type="fig"}). Cortisol was measured using an in-house radioimmunoassay as previously published ([@bb0255]). For three individuals one saliva sample was missing due to insufficient saliva for reliable detection. For these three missing samples (that were all prior to the experimental condition), a value was imputed based on all other cortisol measurements, age and experimental condition. The area under the curve with respect to the increase (AUCi) of cortisol was calculated as previously described ([@bb0205]). Moreover, the cortisol peak response was calculated representing a more dynamic measure of temporal changes as previously published (5th sample--2nd sample) ([@bb0255]).

2.4. Magnetic resonance spectroscopy {#s0030}
------------------------------------

All scans were performed on a 7T MRI scanner (Philips, Cleveland, OH, USA) with a birdcage transmit head coil driven by two amplifiers in combination with a 32 channel receive coil (Nova Medical, Inc.). A T1-weighted MP-RAGE sequence was acquired for voxel placement (174 slices, TR = 4 ms, TE = 1.8 ms, flip angle = 7**°**, field of view = 246 × 246 × 174 mm). Glutamate levels were detected in a 20 × 20 × 20 mm^3^ voxel using an sLASER sequence (semi-localized by adiabatic selective refocusing; TE = 30--36 ms, TR = 5000 ms, 32 averages, max B1 = 17--20 μT, no OVS ([@bb0045])). The TE was either 30 ms in case we could reach a local B1 of 20 μT, or 36 ms in case the local B1 was between 17 and 20 μT. J-difference spectral editing was used to differentiate the GABA signal from other metabolites. The macromolecular contribution to the GABA signal was minimized by using symmetric editing around the macromolecule resonance at 1.7 ppm, alternating the editing pulse between 1.9 ppm (GABA refocused) and 1.5 ppm (GABA undisturbed) ([@bb0015]). GABA-edited ^1^H-MRS spectra were obtained using a MEGA-sLASER sequence (TE = 74 ms, TR = 4000 ms, 64 averages, no OVS ([@bb0015])) in a 25 × 25 × 25 mm^3^ voxel. Non-water suppressed spectra were obtained in order to calculate absolute concentrations of metabolites. Prior to ^1^H-MRS acquisition, RF shimming on the region of interest was used to optimize phase settings of the individual transmit channels. Second order B0 shimming was automatically performed before data acquisition. For tissue segmentation purposes, a whole-brain three-dimensional fast field echo T1-weighted scan was obtained (450 slices, slice thickness = 0.8 mm, TR = 7 ms, TE = 3 ms, flip angle = 8°, field of view = 250 × 200 × 180 mm, 312 × 312 acquisition matrix, SENSE factor 2.7, scan duration = 408 s). The voxel was placed in the mPFC with the posterior edge adjacent to the corpus callosum and the anterior edge placed to avoid signal from the cerebrospinal fluid (25 × 25 × 25 mm^3^ voxel for GABA; 20 × 20 × 20 mm^3^ voxel for glutamate [Fig. 2](#f0010){ref-type="fig"}). To ensure comparable voxel placement before and after the experimental procedure, screenshots of the first scan were used to place the voxel in the second scan session.Fig. 2Representative example of voxel placement (yellow rectangle) in the medial prefrontal cortex (panel A), an sLASER spectrum (panel B) and an edited MEGA-sLASER spectrum (panel C). In the spectra, the red line denotes the individual metabolite fit of respectively glutamate (panel B) or GABA (panel C) and the green line is the residual after fitting the metabolites. Insert: zoom of the GABA peak in the edited MEGA-sLASER spectrum.Fig. 2

2.5. Metabolite quantification {#s0035}
------------------------------

Data from 32 receiver coils were combined after amplitude weighting and phasing based on the water reference signal, and noise decorrelation based on a noise scan. The water reference signal was also used for eddy current correction and as an internal standard for GABA and glutamate quantification. Metabolites (including glutamate) were quantified from conventional MR spectra using LCModel-based software implemented in Matlab (([@bb0195]); NMR Wizard) which relies on *a priori* knowledge of spectral components of metabolites. Measured macromolecules and sixteen simulated metabolite profiles were fitted to each spectrum: taurine (Tau), myo-inositol (m-Ino), glutathione (GSH), glutamine (Gln), glutamate (Glu), GABA, *N*-acetyl aspartyl glutamate (NAAG), *N*-acetyl aspartate (NAA), phosphocreatine (PCr), creatine (Cr), phosphoethanolamine (PE), glycerophosphocholine (GPC), phosphocholine (PCh), lactate (Lac), aspartate (Asp) and glycine (Gly). The baseline of the spectral fit was adjusted by incorporating possible lipid and water artifacts. GABA-edited MR spectra were frequency-aligned with the singlet resonance of choline prior to subtraction of odd and even acquisitions. Fitting of the GABA-edited spectra was performed by frequency-domain fitting of the GABA and creatine resonances to Lorentzian line shapes using in-house Matlab tools ([@bb0020]).

Spectral fitting was assessed based on (i) visual inspection by two independent investigators and (ii) a Cramer Rao lower bound (CRLB) estimate lower than 10% for GABA and glutamate, which is lower than the generally recommended CRLB of 20% ([@bb0200]). The CRLB represents estimates of the standard deviations of the fit for each metabolite. Based on these criteria, one MEGA-sLASER scan was excluded. A typical example of metabolite fits has been included in [Fig. 2](#f0010){ref-type="fig"}. Due to data transfer problems, GABA data was missing for three individuals and we did not have an anatomical scan to calculate GABA and glutamate concentrations for one individual. Glutamate and GABA data were available for 29 and 26 individuals, respectively.

To correct for partial volume effects in the voxel, grey matter (f~GM~), white matter (f~WM~) and CSF(f~CSF~) fractions per voxel were obtained using segmentation of the anatomical images with statistical parametric mapping software (SPM8) according to the unified segmentation method ([@bb0025]) (see Appendix A, Supplementary Method 1 for full description). In short, the sum value for each of the three tissue masks was divided by the sum of all three tissue masks for each voxel, resulting in *f*~GM~ + *f*~WM~ + *f*~CSF~ = 1 (see Appendix A, Supplementary Table 1). Correction for partial volume differences did not change any of the results and we used the corrected values for all analyses (see Appendix A, Supplementary Note 1 for the analyses without partial volume corrections).

2.6. Questionnaires {#s0040}
-------------------

To investigate possible confounding by childhood maltreatment, life events, and daily hassles on cortisol stress reactivity, participants completed validated self-report questionnaires of childhood trauma (Childhood Trauma Questionnaire (CTQ) ([@bb0035])), major life events (Lifetime Stressor Checklist-Revised (LSC-R) ([@bb0270])) and current daily hassles (Dutch Everyday Problem Checklist ([@bb0260])).

2.7. Statistical analysis {#s0045}
-------------------------

### 2.7.1. General {#s0050}

All statistical analyses were carried out using R version 3.2.1 ([@bb0210]). For regression modelling, the Limma package was used ([@bb0235]). There were no outliers (defined as having a Cook\'s Distance \> 1). Age was included as a covariate to adjust for age variation in brain metabolite levels ([@bb0155]). In all regression models, GABA or glutamate levels after the experimental condition, adjusted for baseline GABA or glutamate levels, were used as primary outcome. Since trauma exposure can influence cortisol stress reactivity, we examined if group differences existed for childhood trauma, major life events or daily hassles.

### 2.7.2. Stress exposure: effects on GABA and glutamate levels {#s0055}

The main aim of the current study was to investigate the effects of stress on GABA and glutamate levels. Therefore, we examined the association between GABA or glutamate levels after the experimental condition (stress *versus* control) in a linear regression model while adjusting for age and baseline GABA or glutamate levels. We also calculated the correlations between GABA and glutamate concentrations before and after the experimental condition to examine whether these correlations would differ in the stress compared to the control condition.

### 2.7.3. Stress-induced cortisol levels: effects on GABA and glutamate levels {#s0060}

First we examined whether the cortisol response over time differed between the stress and the control condition using Mixed Model Repeated measures with the nlme package in R. In this model condition, time, age and the interaction between time and condition were modeled as fixed effects and we included a by-subject random effect of intercepts and slopes. If a significant interaction was present between the experimental condition and time, the specific time points between the control and stress condition were identified in planned posthoc tests with Bonferroni adjustment for multiple comparisons. Next, we examined the association between cortisol stress reactivity (expressed as AUCi~CORTISOL~ or peak cortisol response) and longitudinal change in GABA or glutamate levels after the experimental condition in a linear regression with age and baseline GABA or glutamate levels as covariates.

2.8. Reliability ^1^H-MRS measurement {#s0065}
-------------------------------------

To evaluate the reproducibility of ^1^H-MRS measurements over time, we calculated the intraclass correlation coefficient (ICC) for GABA and glutamate in the control condition. Consistent with previous neuroimaging studies, an ICC of 0.7 was deemed acceptable ([@bb0060]).

3. Results {#s0070}
==========

3.1. Group characteristics {#s0075}
--------------------------

No significant group differences were present for age, baseline GABA or glutamate levels in the mPFC, partial volumes in the mPFC voxels, childhood trauma, major life events and minor stressors ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"}).Table 2Glutamate and GABA levels in the total sample and per condition.Table 2VariableTotal (n = 29)[a](#tf0005){ref-type="table-fn"}Control (n = 14)[a](#tf0005){ref-type="table-fn"}Stress (n = 15)[a](#tf0005){ref-type="table-fn"}Glutamate (mM) before (mean, SD)8.7 ± 1.58.6 ± 1.68.8 ± 1.4Glutamate (mM) after (mean, SD)8.0 ± 1.48.3 ± 1.08.0 ± 1.5GABA (mM) before (mean, SD)1.6 ± 0.51.6 ± 0.61.6 ± 0.4GABA (mM) after (mean, SD)1.4 ± 0.51.3 ± 0.51.5 ± 0.4[^1]

3.2. Stress related differences in prefrontal GABA and glutamate levels {#s0080}
-----------------------------------------------------------------------

Stress did not significantly affect prefrontal GABA and glutamate levels (glutamate B = − 0.1 *t* = − 0.2 *p* = 0.86, model fit: F(3,25) = 0.49 R^2^ = 0.06; GABA B = 0.22 *t* = 1.3 *p* = 0.20, model fit: F(3,22) = 3.9 R^2^ = 0.26) ([Fig. 3](#f0015){ref-type="fig"}). Both for GABA and glutamate, the levels before and after the control condition were significantly correlated (GABA *r* = 0.45, *p* = 0.03, Glutamate *r* = 0.43, *p* = 0.04). In contrast, before-after levels were not significantly correlated in the stress condition (GABA *r* = − 0.09 *p* = 0.69, Glutamate *r* = 0.18 *p* = 0.46).Fig. 3Mean glutamate (A) and GABA (B) levels before and after the task in either the control (black) or stress (red) condition. Error bars indicate the standard error per condition. Insert: individual GABA and glutamate levels for each participant.Fig. 3

3.3. Cortisol stress reactivity, GABA and glutamate levels {#s0085}
----------------------------------------------------------

Cortisol levels over time were significantly higher in the stress condition compared to the control condition (Condition × Time interaction F(4,112) = 9.89, *p* \< 0.001). Posthoc tests indicated higher cortisol levels in the stress condition at the time points immediately after the second ^1^H-MRS measurement (t~65min~ B = 4.6 *p* = 0.002 and t~70min~ B = 4.8 *p* \< 0.001) ([Fig. 1](#f0005){ref-type="fig"}). As expected, stress exposure resulted in a larger cortisol peak response (B = 3.9 *t* = 3.2 *p* = 0.003, model fit: F(2,27) = 7.0 R^2^ = 0.29) and a trend towards a higher AUCi~CORTISOL~ (B = 149 *t* = 2.04 *p* = 0.05, model fit: F(2,27) = 2.1 R^2^ = 0.07). However, cortisol release was not associated with changes in either glutamate (AUCi~CORTISOL~ B = 4.7 × 10^− 04^ *t* = − 0.3 *p* = 0.73, model fit: F(3,25) = 0.52 R^2^ = − 0.05; cortisol increase B = − 0.02 *t* = − 0.3, *p* = 0.79, model fit: F(3,25) = 0.5 R^2^ = − 0.06) or GABA levels (AUCi~CORTISOL~ B = 3.4 × 10^− 05^ *t* = 0.08 *p* = 0.93, model fit: F(3,22) = 3.1 R^2^ = 0.20; cortisol increase B = − 0.009 *t* = − 0.3 *p* = 0.73, model fit: F(3,22) = 3.1 R^2^ = 0.20).

### 3.3.1. Reliability ^1^H-MRS signal {#s0090}

In the control group the ICC estimates were similar for GABA (ICC = 0.60) and glutamate (ICC = 0.57), but lower than the 0.7 cut-off deemed acceptable in previous neuroimaging studies that aimed to establish reproducibility between scans ([@bb0060]).

4. Discussion {#s0095}
=============

In the current study, we investigated the influence of acute psychosocial stress on glutamate and GABA levels in the human prefrontal cortex using 7T ^1^H-MRS. Stress exposure did not significantly alter GABA and glutamate levels compared to the control condition. Moreover, the peak and AUCi cortisol response were not associated with changes in prefrontal GABA or glutamate levels. Nonetheless, whereas both GABA and glutamate before and after the control condition were significantly correlated, this was not the case in the stress condition, possibly indicating very subtle stress effects differing across individuals.

4.1. GABA and glutamate changes in response to stress {#s0100}
-----------------------------------------------------

GABAergic and glutamatergic neurotransmission are pivotal for restoring homeostasis after acute stress, with the mPFC and hippocampus constituting two key regions affecting HPA axis activity ([@bb0240]). Rodent studies indicate increased stress-related prefrontal glutamate levels, primarily based on studies carried out in synaptosomes (for review see ([@bb0190])). In the hippocampus either no effect ([@bb0190]) or a rapid increase in glutamate levels or release probability was observed ([@bb0125], [@bb0250]). Also, several hours after acute stress glutamatergic transmission was found to be enhanced, both in the PFC ([@bb9005], [@bb9010]) and in the hippocampus ([@bb0120]). In contrast, acute stress generally decreased frontal and hippocampal GABAergic transmission ([@bb0040]). Some evidence suggests that the direction of GABAergic transmission change after acute stress is stressor dependent, both in the hippocampus (for review see ([@bb0140])) and in the frontal cortex ([@bb0005], [@bb0030]).

Although many rodent studies report GABA and glutamate differences after stress, human studies investigating stress-induced GABA and glutamate levels are scarce. In contrast to our findings of no stress-related differences in GABA and glutamate levels after acute psychosocial stress, two previous ^1^H-MRS studies reported increased glutamate ([@bb0275]) and decreased GABA ([@bb0105]) levels in the prefrontal cortex after chemically induced panic and threat of shock, respectively. However, it is important to note several differences in study methodology. First, we used an extensively validated psychosocial stressor with a social evaluative aspect which induces a robust cortisol response (for review see ([@bb0080])). Nevertheless, it is possible that GABA and glutamate levels are not as susceptible to this type of stressor as to chemically induced panic or threat of shock. In addition, since the stress task needs to be carried out outside of the MR scanner, voxel placement, shimming and voxel localization were done twice, which may have led to more within-subject variation. Moreover, while the previously reported glutamate increase was detected 10 min after stress ([@bb0275]) and the GABA decrease 15 min after stress ([@bb0105]), we measured GABA and glutamate levels at the peak of the cortisol response (30 min after stress) in line with a bidirectional relationship between cortisol levels and GABA and glutamate ([@bb0165]). We cannot exclude that GABA and glutamate levels immediately after stress exposure are more relevant for cortisol stress reactivity than GABA and glutamate levels 30 min after stress. A final difference with previous studies is the use of a 7T scanner enabling better separation of glutamate from glutamine and, in the edited sequence, GABA detection with less macromolecule contamination than at lower field strength. This is particularly relevant as macromolecular content can contribute to \> 30% of the GABA signal ([@bb0015], [@bb0065]).

4.2. GABA and glutamate in stress-related psychopathology {#s0105}
---------------------------------------------------------

Notwithstanding the absence of stress or cortisol effects on prefrontal GABA and glutamate levels, adequate functioning of these systems is crucial for maintaining mental health. In support, GABA system abnormalities have been described in a wide range of stress-related disorders, including major depressive disorder (MDD) ([@bb0145]), post-traumatic stress disorder (PTSD) ([@bb0085]), schizophrenia ([@bb0090]), and general mental health problems after military deployment ([@bb9000]). In addition, differences in the glutamatergic system have also been linked to MDD ([@bb0150]), PTSD ([@bb0185]), and schizophrenia ([@bb0215]). It remains to be determined to what extend stress-related dynamics of these systems are disturbed in stress-related psychopathology.

4.3. GABA and glutamate quantification {#s0110}
--------------------------------------

The GABA and glutamate levels we report are in line with the previously reported human brain concentrations of GABA (± 1 mmol/kg ([@bb0265])) and glutamate (5--15 mmol/kg ([@bb0095])). Direct comparison between our values and those of others is complicated by differences in quantification methodology. Important parameters affecting metabolite concentrations include the quantification software, number of metabolites fitted, partial volumes in the voxel location and MRS data quality checks ([@bb0010], [@bb0245], [@bb0170], [@bb0220]). Our glutamate measurement with the sLASER sequence in the mPFC was less consistent (ICC = 0.57) than previously reported for other brain areas ([@bb0245]). This lower consistency might be inherent to greater physiological variation in the brain region under study or it could be related to the control task completed in between measurements. Alternatively, it could have resulted from less reliable signal due to magnetic field inhomogeneity, as the region of interest was situated near the paranasal sinuses. Importantly, all Cramer Rao lower bounds (CRLBs) were below 10% which indicates that the measurements were of good quality.

4.4. Conclusion {#s0115}
---------------

In conclusion, we did not find a significant effect of acute stress exposure or cortisol stress reactivity on prefrontal GABA and glutamate levels in the human brain. Although GABA and glutamate levels over time were not correlated in the stress condition, possibly indicating very subtle and differential effects of stress on GABA and glutamate across individuals, our findings suggest that a stress effect on GABA and glutamate levels in the medial prefrontal cortex 30 min after psychosocial stress is absent or at least undetectable using current practice ^1^H-MRS.
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[^1]: For GABA total *N* = 26, stress *N* = 12 and control *N* = 14.
